glp-1 coverage MCT2D Who Gets the Shot? GLP-1

Albiglutide: A New GLP-1 Receptor Agonist Option

doi: 10.1111/dom.12885 Summary Keywords lipodystrophy, glucagon-like peptide-1, diabetes, seipin, liraglutide Citation Roumane A, Mcilroy GD, Sommer N, Han W, Heisler LK and Rochford JJ (2024) GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy

Key features Functionally validated using proprietary incretin-bioassays High purity and guaranteed sterile Tested for hormone receptor specificity Endotoxin tested Since these metabolic hormones are biologically active molecules, their functions cant be fully understood through physicochemical analyses alone

During the summer, that can be especially helpful for people dealing with long days, travel, workouts, and the heat